IT1094413B - Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi - Google Patents

Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi

Info

Publication number
IT1094413B
IT1094413B IT22442/78A IT2244278A IT1094413B IT 1094413 B IT1094413 B IT 1094413B IT 22442/78 A IT22442/78 A IT 22442/78A IT 2244278 A IT2244278 A IT 2244278A IT 1094413 B IT1094413 B IT 1094413B
Authority
IT
Italy
Prior art keywords
procedure
preparation
reduced
live vaccines
viral strain
Prior art date
Application number
IT22442/78A
Other languages
English (en)
Other versions
IT7822442A0 (it
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of IT7822442A0 publication Critical patent/IT7822442A0/it
Application granted granted Critical
Publication of IT1094413B publication Critical patent/IT1094413B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225Porcine transmissible gastroenteritis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20061Methods of inactivation or attenuation
    • C12N2770/20064Methods of inactivation or attenuation by serial passage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/815Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT22442/78A 1977-04-21 1978-04-18 Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi IT1094413B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7704348A NL7704348A (nl) 1977-04-21 1977-04-21 Werkwijze voor het bereiden van een geattenueer- de transmissible gastroenteritis(tge)-virusstam voor toepassing in levende vaccins.

Publications (2)

Publication Number Publication Date
IT7822442A0 IT7822442A0 (it) 1978-04-18
IT1094413B true IT1094413B (it) 1985-08-02

Family

ID=19828409

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22442/78A IT1094413B (it) 1977-04-21 1978-04-18 Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi

Country Status (14)

Country Link
US (1) US4159319A (it)
JP (1) JPS53133629A (it)
AU (1) AU525486B2 (it)
BE (1) BE866150A (it)
CA (1) CA1124646A (it)
DE (1) DE2817299A1 (it)
ES (1) ES468935A1 (it)
FR (1) FR2388050A1 (it)
GB (1) GB1597259A (it)
IT (1) IT1094413B (it)
NL (1) NL7704348A (it)
PL (1) PL109646B1 (it)
SU (1) SU971108A3 (it)
YU (1) YU93178A (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601251A1 (fr) * 1986-07-09 1988-01-15 Pensaert Maurice Agent viral non pathogene pour la prevention de la gastroenterite transmissible porcine, son obtention et son utilisation comme vaccin.
ATE220327T1 (de) * 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
ES2218543T3 (es) 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
ES2436317T3 (es) 2010-05-07 2013-12-30 Deutsches Krebsforschungszentrum Parvovirus de roedor modificado capaz de propagarse y difundirse en gliomas humanos
EP2746790B1 (en) 2012-12-24 2019-12-04 Uniwersytet Morski w Gdyni Method and circuit for measuring own and mutual thermal resistances of a magnetic device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
US3704203A (en) * 1967-08-24 1972-11-28 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US3585108A (en) * 1969-07-14 1971-06-15 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US4046875A (en) * 1975-07-14 1977-09-06 Richardson-Merrell Inc. Attenuated TGE virus

Also Published As

Publication number Publication date
NL7704348A (nl) 1978-10-24
SU971108A3 (ru) 1982-10-30
AU525486B2 (en) 1982-11-11
FR2388050A1 (fr) 1978-11-17
IT7822442A0 (it) 1978-04-18
PL109646B1 (en) 1980-06-30
PL206218A1 (pl) 1979-03-26
AU3520378A (en) 1979-10-25
YU93178A (en) 1983-04-30
JPS53133629A (en) 1978-11-21
US4159319A (en) 1979-06-26
ES468935A1 (es) 1978-12-01
FR2388050B1 (it) 1980-10-31
BE866150A (fr) 1978-10-19
DE2817299A1 (de) 1978-10-26
GB1597259A (en) 1981-09-03
CA1124646A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
IT7822442A0 (it) Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi.
IL54390A (en) Live newcastle disease virus vaccine
IT1110864B (it) Procedimento per la preparazione di un vaccino subunitario di tipo 2 per herpes simplex
IT7849126A0 (it) Procedimento per ottenere vaccini acellulari potenziati
IT1192756B (it) Vaccino e procedimento per la sua preparazione
IT1107555B (it) Procedimento di preparazione per liofilizzazione di vaccino meningo coccico senza degradazione della sua efficacia
IT1097765B (it) Procedimento di polimerizzazione per fomare polibutilene
BE880616A (fr) Preparation de vaccin vivant attenue du virus des oeillons
DK133311C (da) Fremgangsmade til fremstilling af en vaccine til bekempelse af marek's syge indeholdende levende ikke-svekket,celleassocieret virus
IT1097352B (it) Procedimento di coltura di virus
IT1098013B (it) Procedimento per la preparazione di furanoni
SE7813201L (sv) Vaccin
IT7821367A0 (it) Preparazione di esteri.
IT1107027B (it) Procedimento per la preparazione del percarbonato sodico
DK143578A (da) 0-phenyldithiophosphonsyreestere fremgangsmaade til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
IT1098369B (it) Procedimento per la preparazione di un ciclopentendione
BE850141A (fr) Vaccin
IT1106289B (it) Procedimento per la preparazione di 4-aril-2(1h)-chinazolinoni
AU513734B2 (en) Live influenza virus vaccine
IT1099035B (it) Procedimento per la preparazione di para-benzochinone
EG14362A (en) Parainfluenza virus vaccine and its preparation
IT1107691B (it) Procedimento per la preparazione di 2-amminometil-fenil solfammati sostituiti
JPS52156920A (en) Proauction of raw influenza virus vaccine
JPS53107411A (en) Production of original strain of live vaccine for bordetela * bronhiseptica infection
JPS5411228A (en) Raw vaccine for newcastle disease virus